Management & Staff
Director, Industry Innovation Programs
Pat Brady, Director, Industry Innovation Programs, joined Genome BC in September 2015 and is focused on advancing genomic tools and technologies through the research continuum to commercialization.
For the last 24 years, Pat has been involved with growing innovative companies, in particular, life science firms. His experience as a venture capitalist and in operations provided hands‐on practice evaluating IP, product development and commercial pathways as well as the market potential of life science technologies.
Pat spent six years in financial and operating roles with Inex Pharmaceuticals (now Arbutus BioPharma) and a clean tech company, DynaMotive Technologies. As a venture capitalist with Growthworks for 18 years, Pat served as a Board Director or Observer for over 13 life science firms and accumulated broad insight for many successful management practices and strategic issues encountered during the commercialization of an innovative technology.
Pat brings with him a deep biopharmaceutical and VC/investment banker network across Canada and internationally. He was the co‐founder of what is now called the BIOTECanada Investor Summit (Whistler, BC) and has gained valuable exposure to the public sector through numerous R&D grants, and as an Expert Panel Chair/participant for the Centre of Excellence for Commercialization and Research (CECR) program.